首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis of pyrrolo(2,3-d)pyridazinones as potent, subtype selective PDE4 inhibitors.
【24h】

Synthesis of pyrrolo(2,3-d)pyridazinones as potent, subtype selective PDE4 inhibitors.

机译:作为有效的亚型选择性PDE4抑制剂的吡咯并(2,3-d)哒嗪酮的合成。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of pyrrolo [2,3-d]pyridazinones was synthesized and tested for their inhibitory activity on PDE4 subtypes A, B and D and selectivity toward Rolipram high affinity binding site (HARBS). New agents with interesting profile were reported; in particular compound 9e showed a good PDE4 subtype selectivity, being 8 times more potent (IC50 = 0.32 microM) for PDE4B (anti-inflammatory) than for PDE4D (IC50 = 2.5 microM), generally considered the subtype responsible for emesis. Moreover the ratio HARBS/PDE4B was particularly favourable for 9e (147), suggesting that the best arranged groups around the pyrrolopyridazinone core are an isopropyl at position-1, an ethoxycarbonyl at position-2, together with an ethyl group at position-6. For compounds 8 and 15a the ability to inhibit TNFalpha production in PBMC was evaluated and the results are consistent with their PDE4 inhibitory activity.
机译:合成了一系列吡咯并[2,3-d]哒嗪酮并测试了它们对PDE4亚型A,B和D的抑制活性以及对Rolipram高亲和力结合位点(HARBS)的选择性。据报道,新的特工具有有趣的形象。特别是化合物9e表现出良好的PDE4亚型选择性,对PDE4B(抗炎)的效力(IC50 = 0.32 microM)是对PDE4D(IC50 = 2.5 microM)的效力的8倍,PDE4D通常被认为是引起呕吐的亚型。此外,比率HARBS / PDE4B特别适合9e(147),这表明在吡咯并哒嗪酮核心周围排列最好的基团是位置1的异丙基,位置2的乙氧羰基以及位置6的乙基。对于化合物8和15a,评估了其在PBMC中抑制TNFα产生的能力,其结果与其PDE4抑制活性一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号